Three Cancer Genome Characterization Centers Select Agilent’s Microarray Platform to Profile Cancers
The National Cancer Institute (NCI) has announced grant recipients for its coveted Cancer Genome Atlas pilot project, including three institutions using microarray platforms from Agilent Technologies ...
According to a recent report by Market.us, the Global DNA Microarray Market size is expected to be worth around USD 4,593.7 Million by 2033 from USD 1,994.6 Million in 2023, growing at a CAGR of 8.7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback